Exploring the influence and threshold effect of low density lipoprotein cholesterol in the progression of retinal arteriosclerosis using deep learning

Authors: Luo Lan, Sun Yaoyao, Zhou Sijin, Yao Yuou, Zhang Shengnan, Ma Tong, Ju Lie, Chang Xiangang, Zhao Mingwei
DOI: 10.3760/cma.j.cn115989-20240609-00148

 

Citation

Luo Lan, Sun Yaoyao, Zhou Sijin, et al. Exploring the influence and threshold effect of low density lipoprotein cholesterol in the progression of retinal arteriosclerosis using deep learning[J]. Chin J Exp Ophthalmol, 2024, 42(12):1127-1133. DOI: 10.3760/cma.j.cn115989-20240609-00148.

ABSTRACT                [Download PDF] [Read Full Text]

Objective  To investigate the effect of low density lipoprotein cholesterol (LDL-C) on the progression of retinal arteriosclerosis by using a deep learning model.

Methods  A cohort study was performed.Data of 1 928 individuals who underwent the medical examination at Beijing Yijiandian Clinic between January 2016 and August 2023 were reviewed, including baseline demographics, physical examination, serological test and fundus photography.Retinal arteriosclerosis was identified using a deep learning model.Five groups were divided according to LDL-C levels, including 389 subjects in group 1 (0.64-1.90 mmol/L), 387 subjects in group 2 (1.91-2.26 mmol/L), 384 subjects in group 3 (2.27-2.57 mmol/L), 385 subjects in group 4 (2.58-2.95 mmol/L), and 383 subjects in group 5 (2.96-6.06 mmol/L).The association between LDL-C levels and progression of retinal arteriosclerosis and the dose-response relationship were analyzed by logistic regression analysis and restricted cubic spline (RCS) regression model.This study adhered to the Declaration of Helsinki.The study protocol was approved by the Ethics Committee of Peking University People’s Hospital (No.2021PHB058-001).Written informed consent was obtained from each subject.

Results  The incidence of retinal arteriosclerosis progression was 22.10% (426/1 928) during the mean follow-up (66.84±6.58) months.The proportions of fundus progression in groups 1, 2, 3, 4, and 5 were 15.68%(61/389), 21.71%(84/387), 21.35%(82/384), 25.71%(99/385), and 26.11%(100/383), respectively, with statistical significant differences among them ( χ 2=15.97, P=0.003).Using group 1 as a reference, LDL-C 2.58-2.95 mmol/L was an independent risk factor for progression of retinal arteriosclerosis ( OR=1.52, 95% CI: 1.04-2.22), and RCS analysis showed an ” L” shaped association.The effect of LDL-C on retinal arteriosclerosis showed a threshold effect, with the risk of retinal arteriosclerosis progression increasing with increasing LDL-C when LDL-C was <2.34 mmol/L ( OR=1.97, 95% CI: 1.10-3.62), and stabilizing when LDL-C was ≥2.34 mmol/L.

Conclusions  LDL-C has a threshold effect on the impact of retinal arteriosclerosis progression, and the threshold is 2.34 mmol/L.

Retina;Arteriosclerosis;Deep learning;Low density lipoprotein cholesterol

Authors Info & Affiliations

Luo Lan
Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing 100044, China
Sun Yaoyao
Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing 100044, China
Zhou Sijin
Beijing Airdoc Technology Co., Ltd., Beijing 100089, China
Yao Yuou
Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing 100044, China
Zhang Shengnan
Beijing Yijiandian Clinic Co., Ltd, Beijing 100033, China
Ma Tong
Beijing Airdoc Technology Co., Ltd., Beijing 100089, China
Ju Lie
Beijing Airdoc Technology Co., Ltd., Beijing 100089, China
Chang Xiangang
Beijing Airdoc Technology Co., Ltd., Beijing 100089, China
Zhao Mingwei
Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing 100044, China
(Read 2 times, 1 visits today)